News

‘Alzheimer’s research has always been bipartisan and it must continue’ : Maria Schriver on the fight against this disease
Journalist and women’s health advocate Maria Shriver discusses an important new advance in the fight against Alzheimer’s ...
Common ailment linked to higher risk of Alzheimer’s disease: ‘Public health priority’
Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.
MIT and Harvard Medical School announce a new research pathway to fight Alzheimer’s disease
In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...
Medpage Today on MSN8h
Alzheimer's Rare Mutation; Autism and Dementia; Using Brain Data to Identify Guilt
Low-dose interleukin-2 as an add-on therapy to riluzole (Rilutek) led to a non-significant reduction in mortality in an ...
New Alzheimer's Test Approved by FDA—What to Know
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...
Alzheimer’s Symptoms May Surface in Your 20s, Study Finds
While most people associate Alzheimer's symptoms with old age, new research suggests signs could begin to show up in your 20s ...
MIT, Harvard scientists make important breakthrough in Alzheimer’s research
MIT and Harvard scientists have discovered potential new targets for treating or preventing Alzheimer's disease.
Alzheimer’s Drugs Arrive in Taiwan to a Host of Questions
Hi, it’s Amber in Hong Kong. Across the strait in Taiwan, breakthrough Alzheimer’s drugs are finally becoming available but ...